According to Tango Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 22.7867. At the end of 2023 the company had a P/S ratio of 27.6.
Year | P/S ratio | Change |
---|---|---|
2023 | 27.6 | 7.49% |
2022 | 25.7 | -0.54% |
2021 | 25.9 |